SCHEMBL1509932

SCHEMBL1509932

CCCC1CCC(C2CCC(c3ccc(OCC)c(F)c3C(F)F)CC2)CC1

nearest known ligand 0.34

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
VEGFA P15692 2/20 0.34
CYP2C9 P11712 1/20 0.32
OPRL1 P41146 2/20 0.31
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
MEN1 O00255 1/20 0.30
MAPK1 P28482 1/20 0.30
KMT2A Q03164 1/20 0.30
FPR2 P25090 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12834683 1.00 VEGFA (0.34) VEGFACYP2C9OPRL1ALDH1A1LMNA
SCHEMBL13025948 0.99 VEGFA (0.33) VEGFACYP2C9OPRL1ALDH1A1LMNA
SCHEMBL7215898 0.91 VEGFA (0.34) VEGFACYP2C9OPRL1ALDH1A1LMNA
SCHEMBL427347 0.88 CYP2C9 (0.35) CYP2C9OPRL1ALDH1A1LMNAMAPT
SCHEMBL17614853 0.88 CYP2C9 (0.35) CYP2C9OPRL1ALDH1A1LMNAMAPT
SCHEMBL12706520 0.88 CYP2C9 (0.35) CYP2C9OPRL1ALDH1A1LMNAMAPT
SCHEMBL1311026 0.88 CYP2C9 (0.35) CYP2C9OPRL1ALDH1A1LMNAMAPT
SCHEMBL15203882 0.88 CYP2C9 (0.35) CYP2C9OPRL1ALDH1A1LMNAMAPT
SCHEMBL4400193 0.88 CYP2C9 (0.35) CYP2C9OPRL1ALDH1A1LMNAMAPT
SCHEMBL15343610 0.88 FPR2 (0.30) VEGFAFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1731493-B1 BENZENE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY CHISSO CORP (JP) 2011-03-23 EP disclosed
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 US disclosed
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed
EP-1731493-A1 BENZENE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY CHISSO CORPORATION (JP) 2006-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device CCND2, YBX1, CNKSR1 VEGFA 1939/4885CYP2C9 3032/4885OPRL1 3494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.